Wholesale Tirzepatide 20mg - Pharmaceutical Grade GLP-1/GIP Receptor Agonist

Tirzepatide 20mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This synthetic peptide demonstrates superior efficacy in metabolic research applications due to its unique dual-agonist mechanism.

As a research compound, Tirzepatide 20mg exhibits multiple pharmacological effects: delaying gastric emptying to promote satiety, reducing hepatic glucose production, and enhancing pancreatic insulin secretion. These properties make it particularly valuable for metabolic syndrome studies.

Our pharmaceutical-grade Tirzepatide 20mg is synthesized under strict GMP conditions, with purity verified by HPLC (>99%) and comprehensive analytical documentation including COA and MSDS. The product is supplied in sterile vials suitable for research applications.

Key advantages of our Tirzepatide 20mg include batch-to-batch consistency, rigorous quality control, and stable long-term supply. The peptide's molecular structure (C225H348N48O68) has been thoroughly characterized to ensure research reliability.

Important Note: This product is intended for laboratory research use only. Not for human or veterinary use. Proper handling procedures should be followed by qualified researchers.